Guanfacine extended-release
NDC 60505-3930, guanfacine, tablet, extended release, from Apotex Corp..
- Product NDC
- 60505-3930
- Status
- Listed
- Labeler
- Apotex Corp.
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA205430
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/60505-3930 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GUANFACINE HYDROCHLORIDE4 mg/1
Pharmacologic classes
Adrenergic alpha2-Agonists [MoA]; Central alpha-2 Adrenergic Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 60505-3930-1 | 60505393001 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (60505-3930-1) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/1c492e87-3406-ddb8-aaf2-e609c2ded503NADAC price for package 60505393001
GET /v1/drugs/nadac/60505393001
Use it
Look up 60505-3930 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/60505-3930 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 60505-3930. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.